MBIO Mustang Bio Inc

Price (delayed)

$0.5114

Market cap

$3.88M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$0.44

Enterprise value

-$11.27M

Relative Growth: Rel. Growth:
Relative Strength: Rel. Strength:
Relative Valuation: Rel. Valuation:
Relative Profitability: Rel. Profitability: 7

Mustang Bio, Inc., a subsidiary of Fortress Biotech, Inc (FBIO)., is a clinical‐stage biopharmaceutical company focused on the development and commercialization of novel cancer immunotherapy products designed to leverage the ...

Highlights
MBIO's EPS has surged by 95% year-on-year and by 6% since the previous quarter
MBIO's equity has surged by 161% year-on-year but it is down by 12% since the previous quarter
The quick ratio has soared by 50% YoY but it fell by 8% QoQ

Key stats

What are the main financial stats of MBIO

MBIO stock price

How has the Mustang Bio stock price performed over time
Intraday
-3.69%
1 week
2.28%
1 month
-11.63%
1 year
-67.22%
YTD
-47.87%
QTD
-27.15%

Financial performance

How have Mustang Bio's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$3.52M
Net income
-$3.03M
Gross margin
N/A
Net margin
N/A
MBIO's net income is down by 11% since the previous quarter but it is up by 7% year-on-year
MBIO's operating income is down by 9% from the previous quarter but it is up by 2.5% YoY

Price vs fundamentals

How does MBIO's price correlate with its fundamentals

Growth

What is Mustang Bio's growth rate over time

Valuation

What is Mustang Bio stock price valuation
P/E
N/A
P/B
0.51
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
MBIO's EPS has surged by 95% year-on-year and by 6% since the previous quarter
MBIO's equity has surged by 161% year-on-year but it is down by 12% since the previous quarter
The P/B is 93% below the 5-year quarterly average of 7.7 and 34% below the last 4 quarters average of 0.8

Efficiency

How efficient is Mustang Bio business performance
MBIO's ROA is up by 41% YoY but it is down by 7% from the previous quarter
The company's return on equity rose by 3.4% QoQ

Dividends

What is MBIO's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for MBIO.

Financial health

How did Mustang Bio financials performed over time
Mustang Bio's total assets is 94% more than its total liabilities
Mustang Bio's current ratio has surged by 52% YoY but it has decreased by 7% QoQ
The quick ratio has soared by 50% YoY but it fell by 8% QoQ
The company's debt is 100% lower than its equity
MBIO's equity has surged by 161% year-on-year but it is down by 12% since the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.